BRBaxtiyor Ravshanov

Baxtiyor Ravshanov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Baxtiyor Ravshanov has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    BIOCHEMICAL AND ANTAGONISTIC PROPERTIES OF BACTERIA ISOLATED FROM A HOT SPRING AND THE COTTON RHIZOSPHERE

    by Malika Nazarova, Husniddin Karimov, Dinara Rajabova, Baxtiyor Ravshanov, Abdumalik Xayrullayev, Nodira Azimova

    This study investigated the biochemical and antagonistic properties of thermophilic and thermotolerant bacteria isolated from the Rayim So‘fi hot spring in Kashkadarya Region, Uzbekistan, and cotton rhizosphere soil. Based on their phenotypic characteristics, two isolates were provisionally identified as Geobacillus sp. and Bacillus sp. Both isolates exhibited proteolytic, amylolytic, and catalase activities, whereas no lipolytic activity was detected. In vitro assays demonstrated that the bacterial isolates inhibited the mycelial growth of the phytopathogenic fungi Fusarium oxysporum and Rhizoctonia solani. These findings indicate that the investigated bacterial isolates may represent promising candidates for the development of biological plant protection strategies.

  • Open Access

    Isolation and purification of antibacterial metabolites from the micromycete Trichoderma asperellum Uz-A4

    by H. Karimov, A. Inkhonova, N. Azimova, B. Turaeva, S. Zakiryaeva, Z. Shakirov, B. Ravshanov, F. Kobilov, M. Isokulov, O. Shukurov, et al.

    The global rise in antibiotic resistance has increased the demand for new natural antibacterial agents derived from microorganisms. This study aimed to isolate and characterize antibacterial metabolites produced by the micromycete Trichoderma asperellum Uz-A4 The strain was cultivated under controlled conditions, and bioactive metabolites were extracted from the culture broth using ethyl acetate. The crude extract and purified fractions were evaluated for antibacterial and anticandidal activities against clinical test strains. Structural identification of the active metabolites was carried out through a combination of GC–MS, LC–MS, NMR, FTIR, and XRD analyses. Several bioactive compounds, including trimethoprim-like metabolite, palmitoleic acid, and D-mannitol, were identified, confirming the fungal origin of these clinically significant molecules. The results demonstrate that T. asperellum Uz-A4 is a promising source of pharmacologically relevant antibacterial metabolites with potential applications in drug discovery and microbial control.